BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9362390)

  • 1. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.
    Benelhadj S; Marcellin P; Castelnau C; Colas-Linhart N; Benhamou JP; Erlinger S; Bok B
    Horm Res; 1997; 48(5):209-14. PubMed ID: 9362390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
    Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
    Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
    Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid function in patients with chronic hepatitis C virus infection under interferon therapy.
    Abdel-Kader ME; Azmy MK; Hassan MA; Ahmad YK; El-Dahshan T; Houssein MA
    J Egypt Soc Parasitol; 2012 Dec; 42(3):761-8. PubMed ID: 23469650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
    Kozielewicz D; Zaleśna A; Dybowska D
    Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
    Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
    Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
    Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
    Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dysthyroidism in patients treated with interferon alpha].
    Chédin P; Chanson P; Duranteau L; Guillausseau PJ; Lubetzki J
    Presse Med; 1994 Nov; 23(36):1659-63. PubMed ID: 7899293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
    Hwang Y; Kim W; Kwon SY; Yu HM; Kim JH; Choe WH
    Korean J Intern Med; 2015 Nov; 30(6):792-800. PubMed ID: 26552454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine.
    Czarnywojtek A; Waligórska-Stachura J; Szczepanek E; Zgorzalewicz-Stachowiak M; Bereszyńska I; Kurdybacha P; Stangierski A; Harasymczuk J; Florek E; Waśko R; Ruchała M
    Neuro Endocrinol Lett; 2012; 33(3):268-72. PubMed ID: 22635082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
    Hass HG; Klein R; Nehls O; Kaiser S
    J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C.
    Inoue A; Koizumi S; Matsuda A; Mizuo H; Iriuda Y; Ikota A; Beniko M; Kosugi T; Matsuya K; Kunita H; Mashio Y
    Endocr J; 2005 Jun; 52(3):293-8. PubMed ID: 16006723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
    Koh LK; Greenspan FS; Yeo PP
    Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid dysfunction in antiviral therapy of chronic hepatitis C.
    Dabrowska MM; Panasiuk A; Flisiak R
    Hepatogastroenterology; 2010; 57(101):826-31. PubMed ID: 21033237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
    Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
    Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: a prospective cohort study.
    Kabbaj N; Guedira MM; El Atmani H; El Alaoui M; Mohammadi M; Benabed K; Lachkar H; Benaïssa A
    Ann Endocrinol (Paris); 2006 Sep; 67(4):343-7. PubMed ID: 17072240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
    Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
    J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.
    Ward DL; Bing-You RG
    Endocr Pract; 2001; 7(1):52-8. PubMed ID: 11250770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.